Journal of the American College of Clinical Pharmacy : JACCP最新文献

{"title":"Comment on “Point-Of-Care Testing in Community Pharmacies to Expand Access to Treatment for Sexually Transmitted Infections”","authors":"Rebekah Cox","doi":"10.1002/jac5.70109","DOIUrl":"https://doi.org/10.1002/jac5.70109","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1099-1100"},"PeriodicalIF":1.5,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of an AI activity to teach interprofessional roles and responsibilities","authors":"Morgan P. Stewart, Sook Hyun Park, Mary Katie Sanders, Amy Holland, John Luk, Sarah Sloan, Veronica Young","doi":"10.1002/jac5.70086","DOIUrl":"10.1002/jac5.70086","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Interprofessional education (IPE) is a core component for preparing health care professionals for collaborative practice. Leveraging technology to support IPE can enhance active team-based learning. At the University of Texas at Austin (UT Austin), a longitudinal IPE course fosters team-based learning through modules aligned with the Interprofessional Education Collaborative (IPEC) core competencies. In the Fall of 2024, an artificial intelligence (AI)-generated image activity was introduced to enhance the roles and responsibilities module, replacing an Interprofessional Pictionary activity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This IPE activity aimed to assess the impact of incorporating an AI-generated image activity on student perceptions of learning outcomes related to IPEC Core Competency #2, roles and responsibilities, compared to a historical cohort who completed the same module using a conventional Interprofessional Pictionary activity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The module engaged 36 interprofessional teams of students from pharmacy, nursing, medicine, and social work. Teams used AI tools to generate images representing assigned professions, focusing on stereotypes, perceptions, and biases. Faculty facilitators guided teams through image analysis, fostering dialogue on professional stereotypes and the implications for collaboration and patient care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Quantitative analysis of student evaluations from 2023 (<i>n</i> = 225) and 2024 (<i>n</i> = 241) revealed similar or improved outcomes for the AI-enhanced module. Significant increases were observed in students' understanding of others' professions (<i>p</i> = 0.008) and perceptions of mutual trust and respect (<i>p</i> = 0.042) after completing the AI activity. A thematic analysis of student comments revealed primary themes of relevance and engagement, reflection on stereotypes and biases, and application to professional development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Leveraging technology to enhance existing IPE teaching methods can enhance student-perceived learning about roles and responsibilities, expose students to emerging technologies, and contribute to a team climate of mutual trust and respect. Health educators have the opportunity to evaluate their current and previously used IPE teaching methods and consider how AI can also serve as a tool to generate","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 8","pages":"816-822"},"PeriodicalIF":1.5,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144897392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists and paramedics: An exploration toward the ideal interprofessional team to deliver home visits in the value-based primary care setting","authors":"Andrea Bush,&nbsp;Tina Benny,&nbsp;Genevieve Hale,&nbsp;Matthew Seamon,&nbsp;Mekaliah Creese","doi":"10.1002/jac5.70087","DOIUrl":"10.1002/jac5.70087","url":null,"abstract":"<div>\u0000 \u0000 <p>The shift in health care toward value-based payment models has allowed for the integration of pharmacists into innovative care models to improve patient outcomes. Home visits are useful in value-based settings as they can enhance care management and help patients with complex needs manage their conditions. However, the ideal interprofessional team to conduct these home visits is unknown. In efforts to improve care and quality outcomes as well as assess feasibility and identify barriers to implementation, an interprofessional home visit team consisting of paramedics and pharmacists was utilized within a managed services organization. Pharmacists and paramedics possess the expertise and skill to manage primary care patients in the home setting to provide medication management and needs assessments. There is limited research on pharmacist-paramedic collaboration in home visits in the value-based primary care setting. In this article, experiences in conducting home visits with pharmacists and paramedics, the role of the pharmacist and the paramedic, and considerations regarding interprofessional home visit care are described in detail.</p>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 8","pages":"694-701"},"PeriodicalIF":1.5,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144897482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of the Pharmacist and Community Health Worker Heart Healthy Clinic Model","authors":"Mitchell L. Struewing,&nbsp;Omolola A. Adeoye-Olatunde,&nbsp;Yuedi Yang,&nbsp;Kourtney A. D. Byrd,&nbsp;Megan E. Conklin,&nbsp;Jasmine D. Gonzalvo,&nbsp;Kalesia Smith,&nbsp;Ashley H. Meredith","doi":"10.1002/jac5.70108","DOIUrl":"10.1002/jac5.70108","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Pharmacist-led interventions have demonstrated success in managing cardiovascular risk factors; addressing social drivers of health (SDOH) is essential to improving health outcomes. Community health workers (CHWs) can help overcome SDOH barriers and enhance care delivery. Little research exists on pharmacist-CHW collaborations, particularly in free clinics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The objectives of this study were to characterize the infrastructure of a pharmacist-CHW managed cardiovascular clinic model and assess whether systolic (SBP) and diastolic blood pressure (DBP) changed over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The Pharmacists' Patient Care Process characterized the model infrastructure aligning pharmacist and CHW roles. This single-center, retrospective study evaluated patients with hypertension engaged in pharmacist-CHW services between February 1, 2023 and September 4, 2024. Data included demographics, as well as clinical and SDOH outcomes. A Linear Mixed Effects Model (LMEM) assessed the relationship between predictor variables, time, and their interaction. Multivariable analysis using LMM included predictors while excluding variables with multicollinearity or limited data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Data were analyzed for 53 unique patients across 231 visits. SBP and DBP decreased significantly over time, with a predicted mean reduction of 9.63 and 7.57 mmHg, respectively (<i>β</i> = −9.63, <i>p</i> = 0.002 and <i>β</i> = −7.57, <i>p</i> &lt; 0.001, respectively). Individuals who had three or more identified medication therapy problems (MTPs) had a significantly higher SBP (<i>β</i> = 19.10, <i>p</i> = 0.001) and DBP (<i>β</i> = 9.60, <i>p</i> = 0.015) than individuals who had no MTPs identified. The CHW provided 100 referrals, often for medical services beyond the scope of the free clinic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study highlights the effectiveness of a pharmacist-CHW cardiovascular clinic model in significantly improving blood pressure outcomes over time. The findings demonstrate the potential to integrate CHWs and address SDOH, ultimately enhancing care delivery for diverse populations. Future research should explore the model's scalability, economic impact, and effectiveness in managing other chronic conditions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":"850-859"},"PeriodicalIF":1.5,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70108","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From Pharmacist to Pharma: Advice on Career Pathways in Drug Development","authors":"William P. Petros,&nbsp;J. Robert Powell","doi":"10.1002/jac5.70105","DOIUrl":"https://doi.org/10.1002/jac5.70105","url":null,"abstract":"<p>There are ever-expanding opportunities in drug development for pharmacists. Mechanisms available to train post-Doctor of Pharmacy (PharmD) graduates for careers in drug development have undergone dramatic evolution, particularly in the past decade. However, there has not been a student or early career-centric summary of these opportunities. Guidance on the training opportunities and pathways available for pharmacists interested in a career in drug development, particularly in the context of the authors' experiences and knowledge of the field, are provided. Past literature guidelines on training programs were reviewed, and recent publications of industry-sponsored fellowship programs are summarized. Limited contemporary publications related to this topic from a global perspective were found; however, recent publications of industry-sponsored fellowship program information revealed some important issues related to program structure and trainee placement. Pharmacists interested in a career in drug development should consider both the program content and pathway they pursue to achieve their ultimate career trajectory.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1023-1026"},"PeriodicalIF":1.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Pharmacist Involvement in Emergency Department Microbiological Culture Follow-Up Services on Clinical Outcomes and Workflow: A Systematic Review","authors":"Elizabeth W. Covington,&nbsp;Adelia Grabowsky,&nbsp;Michal Moore,&nbsp;Adrianna T. Reagan,&nbsp;Leborah Lee,&nbsp;Rachel Cody","doi":"10.1002/jac5.70106","DOIUrl":"https://doi.org/10.1002/jac5.70106","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Patients are often discharged from the emergency department (ED) while results from microbiological cultures are still pending. Most institutions provide culture follow-up, but there is wide variability in the structure and personnel involved. Pharmacists are well suited for involvement in culture follow-up services; though no systematic review has evaluated the impact of pharmacists in this clinical role.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To assess the impact of pharmacists in ED culture follow-up services on: (1) clinical outcomes; and (2) workflow. To characterize pharmacist roles/responsibilities as part of ED culture follow-up services.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A search of the following databases was conducted: Medline, International Pharmaceutical Abstracts, and Web of Science. Studies were included if they described culture follow-up services with pharmacist involvement in an ED setting. Screening and quality assessment were performed using Covidence software and the Newcastle-Ottawa Scale, respectively. Data extraction focused on study design, participants, types of cultures, and clinical and time-based outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirty-three studies met inclusion criteria. Pharmacist involvement was consistently associated with reduced time from culture result to first attempted patient contact (ranging from 9.1–62.3 h, compared with 23.6–72 h without pharmacist involvement). Some studies found absolute reductions in ED revisit or readmission rates ranging from 4.2% to 15.4%, while others found no difference. Pharmacists significantly improved the appropriateness of antimicrobial therapy, with fewer missed interventions and less unnecessary antibiotic use. Current literature is limited by heterogeneity in study designs, small sample sizes, and a lack of randomized controlled trials.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Pharmacist involvement in ED culture follow-up services demonstrates clear benefits in reducing time to initial review and patient contact. Further research is needed to address methodological limitations of current literature and to explore the benefits of negative culture follow-up services, expanded pharmacy services through collaborative practice agreements, and strategies to enhance the efficiency of culture follow-up services.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1046-1060"},"PeriodicalIF":1.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health Disparities Activities During Advanced Pharmacy Practice Experiences: A Pre-Post Analysis of Student Perceptions and Knowledge","authors":"Kristi W. Kelley,&nbsp;E. Kelly Hester,&nbsp;Allison Helmer,&nbsp;Dana G. Carroll","doi":"10.1002/jac5.70104","DOIUrl":"https://doi.org/10.1002/jac5.70104","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The pharmacy profession is increasingly committed to addressing social determinants of health (SDOH) and health disparities (HD). This shift necessitates pharmacy curricula to train learners to identify and address SDOH and HD to improve patient health outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To assess learners' knowledge, attitudes, perceptions, and confidence in providing care to underserved populations experiencing HD during a five-week ambulatory care advanced pharmacy practice experience (APPE) through active learning cases and discussions in addition to direct patient care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This is a retrospective review of pre- and post-survey data completed by fourth-year pharmacy learners on ambulatory care APPE rotations with four clinical faculty members in rural and urban clinics. This was conducted at a single college of pharmacy between May 2019 and April 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 54 paired responses. Learners' confidence in identifying patients with HD and willingness to help them, as well as their knowledge of resources, increased after the assigned learning activities. Learners acknowledged HD's impact on health care outcomes and, after completing rotation activities, maintained their interest in serving patients with limited access and resources.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Learning activities related to HD alongside providing care to patients at risk for HDs on five-week ambulatory care APPEs significantly improved learners' confidence and abilities in identifying and addressing HD among patients. These results emphasize the effectiveness of targeted learning activities in improving pharmacy learners' confidence in serving diverse patient populations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1015-1022"},"PeriodicalIF":1.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient-Reported Adverse Drug Events on Nirmatrelvir–Ritonavir: A Prospective Observational Study of a Pharmacist-Led Follow-Up and Monitoring Service","authors":"Colin R. Dormuth,&nbsp;Anat Fisher,&nbsp;Gregory A. Carney,&nbsp;Davin Shikaze,&nbsp;I Fan Kuo","doi":"10.1002/jac5.70097","DOIUrl":"10.1002/jac5.70097","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>There is a paucity of population-based data on adherence and adverse drug events (ADEs) associated with the treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir and ritonavir (NMV/r). We sought to contribute data on patient-reported treatment adherence and ADEs with NMV/r using data collected by community pharmacists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data on patient-reported NMV/r adherence and ADEs, the study outcomes, were collected by pharmacists through the Paxlovid Follow-up (PAX-F) service, with linkage to administrative data from the British Columbia (BC) Ministry of Health. The cohort study included individuals in BC prescribed NMV/r between January 31, 2022, and December 31, 2022. Pharmacists conducted phone assessments with patients or their caregivers after completion of NMV/r treatment. Responses were recorded in the PharmaNet database, a provincewide data network. Logistic regression was used to identify characteristics associated with the study outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>PAX-F service was provided to 10 200 individuals. Median age was 72 years, and 56.4% were female. There were 87.6% of respondents (<i>n</i> = 9034) who reported completing all 5 days of their NMV/r medication; 7351 individuals with a PAX-F assessment (72.1%) were dispensed medications with a known interaction with NMV/r. 47.8% of respondents (<i>n</i> = 4960) reported experiencing a total of 7439 ADEs, of which 1.5% of ADEs (<i>n</i> = 115 in 79 individuals) were reported to have been managed at a hospital or emergency room. Female sex was associated with an increased risk of nonadherence to NMV/r compared with men (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.41–1.68), and an increased risk of ADEs (OR, 1.32; 95% CI, 1.15–1.53). Nonvaccination was associated with nonadherence to NMV/r (OR, 3.05; 95% CI, 2.41–3.87), but not with reporting an ADE (OR, 1.04; 95% CI, 0.85–1.29).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Nearly half of NMV/r users in BC reported ADEs with treatment, suggesting that careful consideration of the risks and benefits of prescribing NMV/r is warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":"842-849"},"PeriodicalIF":1.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70097","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Education and Training of Today's Clinical Pharmacist","authors":"Sharon See,&nbsp;Branden D. Nemecek,&nbsp;Sheila M. Allen,&nbsp;Ijeoma Agada,&nbsp;Shubha Bhat,&nbsp;Eliza Dy-Boarman,&nbsp;Michelle Fravel,&nbsp;Susan Hamblin,&nbsp;Lauren Hynicka,&nbsp;Kristi Kelley,&nbsp;Wesley D. Kufel,&nbsp;Dianne May,&nbsp;Sarah E. McBane,&nbsp;Milap C. Nahata,&nbsp;Nicholas B. Norgard,&nbsp;Caitlin Schanz,&nbsp;Kyle Schmidt,&nbsp;Chasity Shelton,&nbsp;Jodi Taylor,&nbsp;Evan Williams,&nbsp;Raegan T. Willoughby","doi":"10.1002/jac5.70094","DOIUrl":"10.1002/jac5.70094","url":null,"abstract":"<div>\u0000 \u0000 <p>Today's clinical pharmacists have graduated from a doctor of pharmacy professional degree program, completed residency training, and obtained board certification. Their foundational education consists of an extensive didactic and experiential curriculum with a strong focus on pharmacology and pharmacotherapeutics. The credit hours devoted to pharmacology and pharmacotherapeutics are substantially greater than those of other health care professional degree programs. When combined with the clinical learning acquired through formal, postgraduate residency training, clinical pharmacists are well prepared to address medication therapy problems and serve as essential members of interprofessional health care teams. This commentary details the education and training of clinical pharmacists and how these compare with other members of the health care team and concludes that clinical pharmacists are uniquely positioned to optimize medication outcomes.</p>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":"951-961"},"PeriodicalIF":1.5,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to “The Impact of Pharmacist-Led Interventions on Blood Pressure Control Among Patients With Chronic Kidney Disease: A Randomized Controlled Trial”","authors":"","doi":"10.1002/jac5.70103","DOIUrl":"10.1002/jac5.70103","url":null,"abstract":"<p>R. N. Okoro, I. Ummate, J. D. Ohieku, S. I. Yakubu, and M. O. Adibe, “The Impact of Pharmacist-Led Interventions on Blood Pressure Control Among Patients With Chronic Kidney Disease: A Randomized Controlled Trial,” <i>Journal of the American College of Clinical Pharmacy</i> 5, no. 10 (2022): 1062–1074, https://doi.org/10.1002/jac5.1677.</p><p>The author's name, Ibrahim Umate M.Sc.ED., was corrected to Ibrahim Ummate M.D. in the online version.</p><p>We apologize for this error.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145037975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}